ClassID:

21647

A61K2300/00 - page 19 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#5401
20120204871
2012-08-16

Stable, non-corrosive formulations for pressurized metered dose inhalers

#5402
20120203161
2012-08-09

DEUTERATED WATER AND RIBOFLAVIN SOLUTION FOR EXTENDING SINGLET OXYGEN LIFETIMES IN TREATMENT OF OCULAR TISSUE AND METHOD OF USE

#5403
20120203052
2012-08-09

THERAPEUTIC REGIMEN FOR TREATING CANCER

#5404
20120203014
2012-08-09

Derivatives of N-hydroxybenzamide for treating HIV infections

#5405
20120202892
2012-08-09

Cannabinoid-Containing Compositions and Methods for Their Use

#5406
20120202885
2012-08-09

METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES

#5407
20120202882
2012-08-09

Permeation enhancers for topical formulations

#5408
20120202881
2012-08-09

Novel NIDDM Regimen

#5409
20120202866
2012-08-09

BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ONDANSETRON

#5410
20120202849
2012-08-09

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT/PROPHYLAXIS OF NON-ALCOHOLIC FATTY LIVER DISEASE

#5411
20120202840
2012-08-09

Use of Flubendazole and Vinca Alkaloids for Treatment of Hematological Diseases

#5412
20120202839
2012-08-09

METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS

#5413
20120202835
2012-08-09

Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer

#5414
20120202829
2012-08-09

6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders

#5415
20120202822
2012-08-09

COMBINATION

#5416
20120202820
2012-08-09

PHARMACEUTICAL COMPOSITION HAVING THE ACTIVE SUBSTANCES METFORMIN AND SITAGLIPTIN OR VILDAGLIPTIN

#5417
20120202819
2012-08-09

COMBINATION THERAPY USING A BETA 3 ADRENERGIC RECEPTOR AGONISTS AND AN ANTIMUSCARINIC AGENT

#5418
20120202796
2012-08-09

Method for combating adverse effects arising from antipsychotic treatment

#5419
20120202779
2012-08-09

MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS

#5420
20120202778
2012-08-09

USE OF AT LEAST ONE OMEGA-3 FATTY ACID AND OF AT LEAST ONE POLYPHENOL FOR THE ENDOGENOUS SYNTHESIS OF EICOSAPENTANOIC ACID AND DOCOSAHEXANOIC ACID

#5421
20120202770
2012-08-09

ANIMAL FEEDS AND VETERINARY COMPOSITIONS

#5422
20120202767
2012-08-09

HYALURONIC ACID BASED MUCOADHESIVE THERAPEUTIC COMPOSITION FOR THE PREVENTION AND TREATMENT OF EPITHELIAL AND MUCOSAL LESIONS OF THE HUMAN BODY

#5423
20120202744
2012-08-09

DUAL ANTAGONISM OF ENDOTHELIN TYPE A AND BRADYKININ B1 RECEPTORS FOR TREATING PAIN AND PREVENTING CARTILAGE DEGRADATION

#5424
20120202742
2012-08-09

METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS

#5425
20120202738
2012-08-09

Therapy for enteric infections

#5426
20120202288
2012-08-09

COMPOSITIONS COMPRISING CYCLIC AMP ENHANCERS AND/OR EP LIGANDS, AND METHODS OF PREPARING AND USING THE SAME

#5427
20120201916
2012-08-09

Quality of life of hepatitis C patients with a formulation for administration to the oral mucosa including freeze dried lysate of selected or species and N-acetyl D-glucosamine

#5428
20120201915
2012-08-09

THERAPEUTIC COMPOSITION

#5429
20120201912
2012-08-09

SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVES THEREOF AND HIGH-MONACOLIN K CONTENT RED YEAST RICE EXTRACT

#5430
20120201911
2012-08-09

Herbal composition comprising ginger and goldenrod for the treatment of cold and flu

#5431
20120201909
2012-08-09

Five part herbal cleanse protocol (detoxifying tea, tonifying tea, relaxing tea, parasite tea, intestinal tea) in conjunction with yoga and a vegan alkalinizing food and juice cleanse program

#5432
20120201907
2012-08-09

Nitroxyl Progenitors in the Treatment of Heart Failure

#5433
20120201904
2012-08-09

SKIN EXTERNAL COMPOSITION COMPRISING A SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND THE USE THEREOF

#5434
20120201903
2012-08-09

CYTOPROTECTIVE OR THERAPEUTIC PLANT COMPOSITION

#5435
20120201901
2012-08-09

Topical Antibiotic Formulations

#5436
20120201897
2012-08-09

Composition for inducing tissue regeneration by activating platelet-rich plasma (PRP)

#5437
20120201890
2012-08-09

Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells

#5438
20120201887
2012-08-09

Pharmaceutical formulation

#5439
20120201884
2012-08-09

Extracts, fractions and compositions comprising acetogenins and their applications

#5440
20120201876
2012-08-09

Method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders

#5441
20120201874
2012-08-09

Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt

#5442
20120201864
2012-08-09

Method

#5443
20120201830
2012-08-09

Compositions and methods for treating macular edema

#5444
20120201822
2012-08-09

TUMOR TREATMENT

#5445
20120201821
2012-08-09

Treatment of Gastrointestinal Inflammation and Psoriasis and Asthma

#5446
20120201819
2012-08-09

Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis

#5447
20120201817
2012-08-09

METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST

#5448
20120201815
2012-08-09

METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST

#5449
20120201804
2012-08-09

TISSUE KALLIKREIN FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER

#5450
20120201803
2012-08-09

3-substituted compounds for reducing uric acid

#5451
20120201801
2012-08-09

Co-enzyme Q10 formulations and methods of use

#5452
20120201800
2012-08-09

Methods and Devices for Sustained In-Vivo Release Of an Active Agent

#5453
20120201798
2012-08-09

COMPOSITIONS AND METHODS AND USES RELATED THERETO

#5454
20120201797
2012-08-09

Agent for reducing risk of developing cancer

#5455
20120201786
2012-08-09

METHODS FOR THE USE OF STEM CELLS AND STEM CELL FACTORS IN THE TREATMENT OF SKIN CONDITIONS

#5456
20120201780
2012-08-09

T. CRUZI-DERIVED NEUROTROPHIC AGENTS AND METHODS OF USE THEREFOR

#5457
20120201779
2012-08-09

ANTIHISTAMINE AND ANTIHISTAMINE-LIKE NASAL APPLICATION, PRODUCTS

#5458
20120201747
2012-08-09

System and method for diagnosis and treatment

#5459
20120199516
2012-08-09

METHOD FOR TREATING MULTIPLE SCLEROSIS

#5460
20120199152
2012-08-09

Method for treatment of hair loss with a combination of natural ingredients

#5461
20120199149
2012-08-09

Tobacco compositions

#5462
20120197188
2012-08-02

Methods and apparatus for drug modeling and displaying drug models

#5463
20120197014
2012-08-02

Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity

#5464
20120196937
2012-08-02

Treatment of ophthalmic disorders using urea

#5465
20120196932
2012-08-02

Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism

#5466
20120196931
2012-08-02

Treatment for multiple sclerosis

#5467
20120196928
2012-08-02

RED YEAST RICE EXTRACT HIGH IN MONACOLIN K CONTENT

#5468
20120196896
2012-08-02

Treatment for oxidative stress and/or hypertension

#5469
20120196887
2012-08-02

METHODS AND COMPOSITIONS FOR IMPROVED RIFAMYCIN THERAPIES

#5470
20120196886
2012-08-02

Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer

#5471
20120196882
2012-08-02

Compounds that treat malaria and prevent malaria transmission

#5472
20120196881
2012-08-02

Treatment of pulmonary hypertension with carbonic anhydrase inhibitors

#5473
20120196879
2012-08-02

Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors

#5474
20120196877
2012-08-02

COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS

#5475
20120196875
2012-08-02

PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES

#5476
20120196870
2012-08-02

Combination therapy

#5477
20120196867
2012-08-02

COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR

#5478
20120196850
2012-08-02

ASSOCIATION OF A SINUS NODE If CURRENT INHIBITOR AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

#5479
20120196840
2012-08-02

Compositions and methods for treating, reducing, ameliorating, or preventing infections

#5480
20120196837
2012-08-02

Method of treating frailty

#5481
20120196830
2012-08-02

KITS AND IMPROVED COMPOSITIONS FOR TREATING LOWER URINARY TRACT DISORDERS

#5482
20120196829
2012-08-02

Method of using β-hydroxy-β-methylbutyrate for the treatment of disease conditions

#5483
20120196828
2012-08-02

SENSITIZATION OF CANCER CELLS TO TREATMENT

#5484
20120196821
2012-08-02

METHOD AND FORMULATION FOR THE CONTROL OF PARASITES

#5485
20120196813
2012-08-02

Glycoside derivative and uses thereof

#5486
20120196811
2012-08-02

VETERINARY PHARMACEUTICAL COMPOSITION AND METHOD (ALTERNATIVES) FOR THE PROPHYLAXIS AND TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT AND INTOXICATIONS OF DIVERSE ETIOLOGY IN ANIMALS

#5487
20120196801
2012-08-02

Wound-healing, anti-ambustial, regenerating, and anti-viral pharmaceutical formula for local administration

#5488
20120196794
2012-08-02

Combinations of Hepatitis C Virus Inhibitors

#5489
20120196791
2012-08-02

COMBINATION THERAPIES USING ANTIBACTERIAL AMINOGLYCOSIDE COMPOUNDS

#5490
20120196363
2012-08-02

Method for modulating activity of T lymphocytes

#5491
20120196057
2012-08-02

COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3

#5492
20120195989
2012-08-02

Carboxymethylarginine Production Inhibitor and Collagen Denaturation Inhibitor

#5493
20120195987
2012-08-02

SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING EPA OR DERIVATIVES THEREOF, OPTIONALLY, DHA OR DERIVATIVES THEREOF AND MONACOLIN K

#5494
20120195986
2012-08-02

Preventing or treating periodontal diseases by herbal extract

#5495
20120195984
2012-08-02

DIAGNOSIS AND TREATMENT OF THE PRODROMAL SCHIZOPHRENIC STATE

#5496
20120195983
2012-08-02

Treatment of specific cardiovascular conditions with nitrite

#5497
20120195982
2012-08-02

Injectible, biocompatible synthetic bone growth composition

#5498
20120195980
2012-08-02

Method, composition and package for bowel cleansing

#5499
20120195978
2012-08-02

CAPCNA PEPTIDE THERAPEUTICS FOR CANCER

#5500
20120195976
2012-08-02

METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION

#5501
20120195972
2012-08-02

Ophthalmic formulations and uses thereof

#5502
20120195971
2012-08-02

Method for Preparing Mechanically Macerated Demineralized Bone Materials and Compositions Comprising the same

#5503
20120195970
2012-08-02

Homeopathic formulations for treatment of herpes virus symptoms

#5504
20120195969
2012-08-02

TREATMENT OF ACNE BY CONDITIONED MEDIA

#5505
20120195965
2012-08-02

Solid dosage form comprising a fibrate

#5506
20120195963
2012-08-02

HIGHLY PURIFIED ETHYL EPA AND OTHER EPA DERIVATIVES

#5507
20120195961
2012-08-02

Use of spinosyns and spinosyn compositions against herpesviridae viral infections

#5508
20120195960
2012-08-02

Post-exposure therapy of influenza A infections

#5509
20120195955
2012-08-02

Sublingual films

#5510
20120195946
2012-08-02

Topical skin care compositions and methods

#5511
20120195945
2012-08-02

Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly

#5512
20120195942
2012-08-02

DOSAGE FORMS OF ACTIVE INGREDIENTS CONTAINING HYDROXYSTILBENE FOR TREATING MENOPAUSAL COMPLAINTS

#5513
20120195939
2012-08-02

PARENTERAL COMPOSITION COMPRISING MICROSPHERES WITH A DIAMETER BETWEEN 10 AND 20 MICRONS

#5514
20120195938
2012-08-02

FORMULATIONS AND METHODS FOR RECOVERY FROM DENTAL SURGERY

#5515
20120195935
2012-08-02

MICROBUBBLE ASSISTED VIRAL DELIVERY

#5516
20120195921
2012-08-02

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

#5517
20120195914
2012-08-02

Deoxycorticosterone induced elastin production

#5518
20120195911
2012-08-02

Method of treatment of cancer patients

#5519
20120195880
2012-08-02

Modulation of synaptic maintenance

#5520
20120195873
2012-08-02

METHODS OF ATTENUATING THE LOSS OF FUNCTIONAL STATUS

#5521
20120195871
2012-08-02

STABLE AQUEOUS SUSPENSION

#5522
20120195869
2012-08-02

Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects

#5523
20120195856
2012-08-02

Method of treating patients with cardiovascular illness

#5524
20120195855
2012-08-02

METHODS FOR UP-REGULATING ANTIGEN EXPRESSION IN TUMORS

#5525
20120195854
2012-08-02

Granulysin in immunotherapy

#5526
20120195827
2012-08-02

Myocardial perfusion imaging methods and compositions

#5527
20120190909
2012-07-26

Uses of IL-12 in hematopoiesis

#5528
20120190752
2012-07-26

EXO-S-MECAMYLAMINE METHOD, USE, AND COMPOUND FOR TREATMENT

#5529
20120190742
2012-07-26

Method for treating eczema

#5530
20120190739
2012-07-26

EP2 and EP4 agonists as agents for the treatment of influenza a viral infection

#5531
20120190734
2012-07-26

COMPOUNDS AND COMPOSITIONS FOR TREATING INFECTION

#5532
20120190731
2012-07-26

Methods and compositions to reduce oxidative stress

#5533
20120190720
2012-07-26

Combination Therapy With Parp Inhibitors

#5534
20120190719
2012-07-26

METHODS OF TREATING MOTOR DISORDERS WITH ALPHA-2B ANDRENERGIC RECEPTOR AGONISTS

#5535
20120190717
2012-07-26

Methods and compositions for increasing the anaerobic working capacity in tissues

#5536
20120190715
2012-07-26

Highly penetrating compositions and methods for treating pathogen-induced disordered tissues

#5537
20120190696
2012-07-26

Inhibitors of fatty acid binding protein (FABP)

#5538
20120190691
2012-07-26

PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES

#5539
20120190676
2012-07-26

INHIBITORS OF MTOR KINASE AS ANTI-VIRAL AGENTS

#5540
20120190671
2012-07-26

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

#5541
20120190661
2012-07-26

Androgen composition for treating an opthalmic condition

#5542
20120190658
2012-07-26

Method And Composition For The Treatment Of Adverse Skin Conditions

#5543
20120190655
2012-07-26

Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine

#5544
20120190646
2012-07-26

Compositions Comprising Thalidomide and Artemisinin for the Treatment of Cancer

#5545
20120190643
2012-07-26

Carbohydrate composition for flat glucose response

#5546
20120190638
2012-07-26

Methods of treating hematologic cancers

#5547
20120190637
2012-07-26

COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS

#5548
20120190636
2012-07-26

Composition for prophylaxis or treatment of urinary system infection and method thereof

#5549
20120190633
2012-07-26

Monophosphorylated lipid A derivatives

#5550
20120190632
2012-07-26

Anti-bacterial infection, inflammation, and leukemia composition and use thereof

#5551
20120190003
2012-07-26

ORGAN ARREST, PROTECTION, PRESERVATION AND RECOVERY

#5552
20120189734
2012-07-26

Nutritional Composition for Lactating Women

#5553
20120189725
2012-07-26

Topical skin care formulations comprising botanical extracts

#5554
20120189723
2012-07-26

Herbal composition for reducing ADD/ADHD and method thereof

#5555
20120189722
2012-07-26

Dietary supplement stimulating the male sexual function

#5556
20120189721
2012-07-26

Methods and compositions for heavy metal detoxification

#5557
20120189718
2012-07-26

Pharmaceutical composition for dissolving and eliminating pathological tissues and pathogens and its usage

#5558
20120189717
2012-07-26

Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting

#5559
20120189716
2012-07-26

Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting

#5560
20120189715
2012-07-26

COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE AND USES THEREOF

#5561
20120189714
2012-07-26

Compositions including beta-hydroxy-beta-methylbutyrate

#5562
20120189710
2012-07-26

ANTIBACTERIAL COMPOSITIONS

#5563
20120189708
2012-07-26

Compositions and soft tissue replacement methods

#5564
20120189703
2012-07-26

Enzyme Delivery Systems and Methods of Preparation and Use

#5565
20120189701
2012-07-26

COMBINATION THERAPY WITH THIOCOLCHICINE DERIVATIVES

#5566
20120189691
2012-07-26

Drug carrier and drug carrier kit for inhibiting fibrosis

#5567
20120189690
2012-07-26

Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein

#5568
20120189684
2012-07-26

Skincare compositions

#5569
20120189682
2012-07-26

Inhibition of biofilm organisms

#5570
20120189673
2012-07-26

POLYPEPTIDES AND USES THEREOF

#5571
20120189672
2012-07-26

USE OF AEROSOLIZED CYCLOSPORINE FOR PREVENTION AND TREATMENT OF PULMONARY DISEASE

#5572
20120189651
2012-07-26

Active agent complex and formulation comprising the active agent complex

#5573
20120189641
2012-07-26

COMBINATION ANTI-CANCER THERAPY

#5574
20120189635
2012-07-26

Methods for Treating or Preventing Malaria by Administering an Antibody that Specifically Binds Angiopoietin-2 (Ang-2)

#5575
20120189631
2012-07-26

Pharmaceutical composition for treating ischemic events

#5576
20120189626
2012-07-26

TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS

#5577
20120189614
2012-07-26

Inhibitors of filovirus entry into host cells

#5578
20120189612
2012-07-26

COMPOSITIONS AND METHODS FOR TREATING CANCER WHILE PREVENTING OR REDUCING CARDIOTOXICITY AND/OR CARDIOMYOPATHY

#5579
20120189607
2012-07-26

METHOD OF REGULATING FERTILIZING ABILITY USING CYCLIC ADP-RIBOSE AND CD38

#5580
20120189602
2012-07-26

Treatment and prevention of pulmonary conditions

#5581
20120189600
2012-07-26

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES

#5582
20120189591
2012-07-26

Compositions and soft tissue replacement methods

#5583
20120189590
2012-07-26

Compositions and soft tissue replacement methods

#5584
20120189589
2012-07-26

Compositions and soft tissue replacement methods

#5585
20120189588
2012-07-26

Compositions and Methods for Implantation of Processed Adipose Tissue and Processed Adipose Tissue Products

#5586
20120189586
2012-07-26

Human Placental Derived Extracellular Matrix and Uses Therof

#5587
20120189585
2012-07-26

METHOD AND COMPOSITION FOR RESTORATION OF AGE-RELATED TISSUE LOSS IN THE FACE OR SELECTED AREAS OF THE BODY

#5588
20120189577
2012-07-26

USE OF IL-12 TO INCREASE SURVIVAL FOLLOWING ACUTE EXPOSURE TO IONIZING RADIATION

#5589
20120189576
2012-07-26

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)

#5590
20120189575
2012-07-26

Oligodendrocyte Production from Multipotent Neural Stem Cells

#5591
20120189573
2012-07-26

Methods of using death receptor agonists and EGFR inhibitors

#5592
20120189567
2012-07-26

Artemisinin derivatives with natural amino acids, peptides, and amino sugars for skin imperfections and infection in mammals

#5593
20120189565
2012-07-26

Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof

#5594
20120189556
2012-07-26

PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND CORTICOSTEROIDS

#5595
20120189537
2012-07-26

Nitrile derivatives and their pharmaceutical use and compositions

#5596
20120186356
2012-07-26

Synthetic synovial fluid compositions and methods for making the same

#5597
20120184621
2012-07-19

Method for treating phytophotodermatitis

#5598
20120184620
2012-07-19

Antioxidant composition

#5599
20120184610
2012-07-19

Methods and formulations for treating ineffective or decreased esophagal motility

#5600
20120184609
2012-07-19

Vitamin C and vitamin K, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant

#5601
20120184601
2012-07-19

ANTIVIRAL OLIGONUCLEOTIDES

#5602
20120184570
2012-07-19

Theophylline derivative inhibits osteoporosis

#5603
20120184556
2012-07-19

SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS

#5604
20120184552
2012-07-19

LATANOPROST-CONTAINING AQUEOUS EYE DROPS AND METHOD FOR INHIBITING ADSORPTION OF LATANOPROST TO RESIN

#5605
20120184539
2012-07-19

Heterocyclic derivatives and their use in the treatment of neurological disorders

#5606
20120184536
2012-07-19

COMPOSITIONS COMPRISING SPECIFIC UGT INHIBITORS AND METHODS OF USE THEREOF

#5607
20120184529
2012-07-19

COMBINATION THERAPY

#5608
20120184528
2012-07-19

7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

#5609
20120184527
2012-07-19

1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

#5610
20120184525
2012-07-19

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

#5611
20120184517
2012-07-19

TREATMENT OF DISEASES WITH ALTERED SMOOTH MUSCLE CONTRACTILITY

#5612
20120184516
2012-07-19

sGC stimulators

#5613
20120184504
2012-07-19

"The Use of a PAR-1 Antagonist in Combination with a P2Y12 ADP Receptor Antagonist for Inhibition of Thrombosis"

#5614
20120184503
2012-07-19

Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection

#5615
20120184497
2012-07-19

DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS

#5616
20120184494
2012-07-19

MULTIPLE MYELOMA PROGNOSIS AND TREATMENT

#5617
20120184490
2012-07-19

Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)

#5618
20120183634
2012-07-19

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#5619
20120183630
2012-07-19

Compositions and methods for stimulating wound healing

#5620
20120183627
2012-07-19

Compositions for the treatment of hemorrhoids and related diseases

#5621
20120183626
2012-07-19

ANTISEPTIC OINTMENT COMPRISING BENTONITE INTERCALATED WITH SILVER, COPPER OR ZINC FOR EXTERNAL APPLICATION

#5622
20120183621
2012-07-19

Synergistic combinations to reduce particle dose for targeted treatment of cancer and its metastases

#5623
20120183617
2012-07-19

Composition and method for treatment of diabetes

#5624
20120183616
2012-07-19

Long acting insulin composition

#5625
20120183612
2012-07-19

Matrix for sustained, invariant and independent release of active compounds

#5626
20120183607
2012-07-19

Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials

#5627
20120183604
2012-07-19

Treatment of triple receptor negative breast cancer

#5628
20120183602
2012-07-19

Lipid formulation

#5629
20120183600
2012-07-19

NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS

#5630
20120183593
2012-07-19

HYDROGELS USED TO DELIVER MEDICAMENTS TO THE EYE FOR THE TREATMENT OF POSTERIOR SEGMENT DISEASES

#5631
20120183586
2012-07-19

Method of obtaining viable small tissue particles and use for tissue repair

#5632
20120183563
2012-07-19

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use

#5633
20120183548
2012-07-19

IL-27 Antagonists for Treating Inflammatory Diseases

#5634
20120183546
2012-07-19

TREATMENT OF OVARIAN CANCER USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE

#5635
20120183536
2012-07-19

METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE TREATMENT OF CANCER

#5636
20120183535
2012-07-19

Use of inhibitors of bruton's tyrosine kinase (Btk)

#5637
20120183526
2012-07-19

COMPOSITION FOR PREVENTING OR TREATING LIVER TOXICITY COMPRISING GALGEUNTANG OR LACTIC ACID BACTERIA FERMENTED GALGEUNTANG

#5638
20120183521
2012-07-19

Equine nutritional supplement

#5639
20120183519
2012-07-19

TREATMENT OF ERECTILE DYSFUNCTION USING PLATELET-RICH PLASMA

#5640
20120183516
2012-07-19

Lactic acid bacteria and bifidobacteria for treating endotoxemia

#5641
20120183504
2012-07-19

COMPOSITION AND USE OF PROBIOTIC STRAIN GM-263 (ADR-1) IN TREATING RENAL FIBROSIS IN DIABETES

#5642
20120183502
2012-07-19

COMBINATION THERAPY FOR LYSOSOMAL STORAGE DISEASES

#5643
20120183501
2012-07-19

NOVEL METHOD FOR TREATMENT OF SKIN WOUNDS AND PREPARATIONS FOR IMPLEMENTATION OF SAME

#5644
20120183472
2012-07-19

IMMUNOTHERAPY OF B-CELL MALIGNANCIES USING ANTI-CD22 ANTIBODIES

#5645
20120183471
2012-07-19

Specific binding proteins and uses thereof

#5646
20120179090
2012-07-12

TRANSMUCOSAL DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE THEREOF

#5647
20120178915
2012-07-12

PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF

#5648
20120178816
2012-07-12

Carbamide peroxide treatments for the reproductive tract

#5649
20120178812
2012-07-12

Pharmaceutical formulations containing lipoic acid derivatives

#5650
20120178803
2012-07-12

Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells

#5651
20120178801
2012-07-12

Compositions and its use in treating obesity or inducing weight loss

#5652
20120178799
2012-07-12

ENERGY BEVERAGE WITH CREATINE AND CAFFEINE COMBINATION

#5653
20120178791
2012-07-12

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)

#5654
20120178782
2012-07-12

COMPOSITIONS AND METHODS FOR TREATING PROLIFERATIVE DISEASES

#5655
20120178777
2012-07-12

Medicaments for inhibiting thrombus formation

#5656
20120178772
2012-07-12

Compositions comprising enzyme-cleavable oxycodone prodrug

#5657
20120178731
2012-07-12

Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria

#5658
20120178727
2012-07-12

Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic

#5659
20120178724
2012-07-12

Compositions for Reducing the Incidence of Drug Induced Arrhythmia

#5660
20120178674
2012-07-12

MIXTURE OF NON-DIGESTIBLE OLIGOSACCHARIDES FOR STIMULATING THE IMMUNE SYSTEM

#5661
20120178667
2012-07-12

METHODS FOR TREATING SEPTIC SHOCK

#5662
20120178164
2012-07-12

Treating cardiovascular tissue

#5663
20120178051
2012-07-12

Anesthesia delivery system

#5664
20120177760
2012-07-12

COSMETIC OR DERMOTOLOGICAL COMPOSITION CONTAINING HYDROLYZATES MADE OF PLANT EXTRACTS

#5665
20120177759
2012-07-12

Compositions and methods for increasing lifespan and health span

#5666
20120177757
2012-07-12

Natural Preparation for Treatment of Skin Sores and Lesions

#5667
20120177756
2012-07-12

Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response

#5668
20120177753
2012-07-12

MULTIFUNCTIONAL TOPICAL FORMULATION FOR THE TREATMENT OF ACNE VULGARIS AND OTHER SKIN CONDITIONS

#5669
20120177752
2012-07-12

NUTRITIONAL COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE

#5670
20120177751
2012-07-12

Pediculosis Treatment and Prophylaxis

#5671
20120177750
2012-07-12

Methods for inhibiting sensory nerves by topically administering strontium-containing compositions to keratinized skin

#5672
20120177743
2012-07-12

Combinations and modes of administration of therapeutic agents and combination therapy

#5673
20120177736
2012-07-12

METHOD FOR TREATING A PATIENT IN NEED OF ASPIRIN THERAPY

#5674
20120177735
2012-07-12

Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders

#5675
20120177732
2012-07-12

CONCENTRATION AND MENTAL PERFORMANCE AMPLIFYING FORMULATION

#5676
20120177731
2012-07-12

Controlled release formulations of levodopa and uses thereof

#5677
20120177718
2012-07-12

WOUND-COVERING MATERIAL

#5678
20120177715
2012-07-12

Heparin cofactor II fragments with anti-inflammatory and anti-coagulant activity

#5679
20120177713
2012-07-12

Nano silver-zinc oxide composition

#5680
20120177691
2012-07-12

FUCOSYLLACTOSE AS BREAST MILK IDENTICAL NON-DIGESTIBLE OLIGOSACCHARIDE WITH NEW FUNCTIONAL BENEFIT

#5681
20120177668
2012-07-12

IMMUNOMODULATING COMPOSITIONS COMPRISING INTERLEUKIN 13 INHIBITORS AND USES THEREFOR

#5682
20120177666
2012-07-12

ANTI-TGF-BETA RECEPTOR II ANTIBODIES

#5683
20120177650
2012-07-12

THERAPY FOR ENTERIC INFECTIONS

#5684
20120177644
2012-07-12

Mesenchymal stem cell differentiation

#5685
20120177642
2012-07-12

Methods of treating inflammatory and autoimmune diseases with natalizumab

#5686
20120177633
2012-07-12

Methods for accelerating the healing of connective tissue injuries and disorders

#5687
20120177631
2012-07-12

Composition for Health Promoting Compounds

#5688
20120177624
2012-07-12

ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT

#5689
20120177623
2012-07-12

Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health

#5690
20120177621
2012-07-12

Enhancement of Allogeneic Hematopoietic Stem Cell Transplantation

#5691
20120177619
2012-07-12

COMPOSITION COMPRISING A HAEMATIC COMPONENT AND ITS USE FOR THE TREATMENT OF DEGENERATIVE JOINT DISEASE

#5692
20120177617
2012-07-12

Composition for Providing Relief of Undesired Body Odours

#5693
20120177610
2012-07-12

Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins

#5694
20120177602
2012-07-12

Dissolution aids for oral peptide delivery comprising a biguanide

#5695
20120177601
2012-07-12

TREATMENT OF HEPATITIS C VIRUS INFECTIONS

#5696
20120177600
2012-07-12

Compositions and methods for inducing or enhancing connective tissue repair

#5697
20120177596
2012-07-12

METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES

#5698
20120177595
2012-07-12

Multimeric IL-15 soluble fusion molecules and methods of making and using same

#5699
20120177594
2012-07-12

Polyion complex comprising PHD2 expression inhibiting substance

#5700
20120177591
2012-07-12

Co-Therapy for Diabetic Conditions